Back to Grants
FEDERAL
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
This grant funds research aimed at translating nanotechnology interventions for cancer treatment.
About this program
The Toward Translation of Nanotechnology Cancer Interventions (TTNCI) grant supports innovative research that focuses on the application of nanotechnology in cancer therapies. It is designed for researchers and institutions engaged in developing novel nanotechnology-based solutions to improve cancer treatment outcomes. The grant encourages collaboration among scientists, engineers, and healthcare professionals to foster advancements in this critical area of cancer research.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and other research entities focused on cancer intervention technologies.